Thomas J. McGinnis
Abstract
In 2001, the U.S. Food and Drug Administration (FDA) launched numerous initiatives to assure the availability of medical products for the treatment of injuries that could be caused by terrorists using biologic, chemical, or nuclear agents.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In 2001, the U.S. Food and Drug Administration (FDA) launched numerous initiatives to assure the availability of medical products for the treatment of injuries that could be caused by terrorists using biologic, chemical, or nuclear agents.
Key concepts: Medicine, Food and drug administration, Drug approval, Medical emergency, Drug, Pharmacology